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CASE REPORT
Listeria monocytogenes associated 
kerato-conjunctivitis in four horses in Norway
Tobias Revold1*, Takele Abayneh1,2, Hege Brun‑Hansen1, Signe L. Kleppe1,3, Ernst‑Otto Ropstad1, 
Robert A. Hellings4 and Henning Sørum1
Abstract 
Listeria monocytogenes has been reported to cause various infectious diseases in both humans and animals. More 
rarely, ocular infections have been reported. To our knowledge, only two cases of Listeria keratitis have been described 
in horses. We report kerato‑conjunctivitis in four Norwegian horses associated with L. monocytogenes. Clinically, all 
cases were presented with recurrent unilateral kerato‑conjunctivitis. L. monocytogenes bacteria were isolated from 
swab samples from all cases, and cytology carried out in 3 cases was indicative of L. monocytogenes infection. The 
present report describes the first known cases in which L. monocytogenes has been isolated from keratitic lesions in 
horses in Norway. A potential risk factor may be feeding of silage or haylage, but other sources of infection cannot be 
ruled out. The phenotypic features including antimicrobial susceptibility and serotype of the isolates are described. 
Laboratory detection of L. monocytogenes demands extra caution since only low numbers of bacteria were detected 
in the eye‑swabs, probably due to the low volume of sample material and the intracellular niche of the bacterium. A 
general poor response to treatment in all these cases indicates that clinicians should pay extra attention to intensity 
and duration of treatment if L. monocytogenes is identified in connection with equine kerato‑conjunctivitis.
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Background
Listeria monocytogenes is an aerobic, Gram positive rod 
that can be found ubiquitously in nature, but is also capa-
ble of causing severe disease [1, 2]. Sheep, cattle, goats 
and chickens are considered to be the most suscepti-
ble species [3], but all animals including humans can 
be infected [1]. The bacterium is also recognized as an 
important foodborne pathogen [4]. Septicemia, encepha-
litis or abortions are the most common clinical manifes-
tations of infection [2], but ocular symptoms may also be 
seen. In food animal species ocular symptoms are most 
commonly associated with infections affecting the cen-
tral nervous system [5]. The term “silage eye” refers to 
listerial kerato-conjunctivitis, and may involve uveitis 
with hypopyon and miosis [6, 7]. In a questionnaire sur-
vey in England, “silage eye” was recognized as the most 
common clinical manifestation of listerial infection in 
dairy cattle, but the study did not include bacteriological 
data [6].
In humans, conjunctivitis is the most common ocu-
lar presentation of L. monocytogenes infection. Listerial 
conjunctivitis may either be endogenous in patients with 
meningitis, or exogenous [8]. Human cases of listerial 
keratitis and endophthalmitis have also been reported 
[8–12]. Human listerial endophthalmitis has been associ-
ated with a characteristic pigmented hypopyon and ele-
vated intraocular pressure [8, 13].
Although listeriosis is less common in horses than in 
ruminants, there have been reports on abortions [2, 14, 
15], intra-uterine infection [16, 17], meningo-enceph-
alitis [18–20] and septicaemia [17, 18, 21–24]. The 
authors are only aware of two previously reported cases 
of equine kerato-conjunctivitis associated with L. mono-
cytogenes [25, 26]. This report describes four cases of 
equine kerato-conjunctivis in Norway. The clinical course 
of the disease, as well as microbiological features and 
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antimicrobial susceptibility (both in vitro and in vivo) of 
L. monocytogenes isolated from all 4 cases are described.
Case presentations
Case 1
A 12-year-old brown Standardbred mare with a 
12  months history of unilateral recurrent kerato-con-
junctivitis was presented to the field practice of the Nor-
wegian School of Veterinary Science (NSVS). The horse 
was fed plastic wrapped silage and a commercial concen-
trate mix. Two previous attempts to treat the horse with 
topical fucidic acid eyedrops (Fucithalmic1) and oxytetra-
cyclin/polymyxin B (Terramycin-Polymyxin B2) eye oint-
ment were unsuccessful.
The ophthalmic examination was performed using a 
focal light source and revealed mild blepharospasm of 
the right eye with a mild mucopurulent discharge. The 
palpebral conjunctivae were moderately hyperaemic and 
chemotic. Direct and consensual pupillary light reflexes 
were normal, and no sign of miosis or aqueous flare were 
seen. Multiple grayish-white sub-epithelial opacities were 
observed in the central part of the cornea, with an irreg-
ular overlying epithelial surface in an area of approxi-
mately 5 × 5 mm. This area was surrounded by a diffuse 
stromal edema covering approximately half of the cornea. 
A bacterial swab was collected from the corneal lesion, 
and transferred to a sterile transport medium. The fluo-
rescein dye test was negative.
The preliminary diagnosis was bacterial kerato-con-
junctivitis, and treatment with chloramphenicol eye oint-
ment (Chloramphenicol3) 3–4 times daily was initiated. 
L. monocytogenes and Micrococcus sp. were cultured 
from the bacterial swab. The L. monocytogenes was con-
sidered to be of potential clinical relevance, and was 
found to be sensitive to chloramphenicol. However, no 
improvement was observed upon re-examination 15 days 
later. A new bacterial swab confirmed the continuous 
presence of L. monocytogenes. Treatment was altered to 
topical ampicillin (Pentrexyl 500  mg4 in 5  ml sterile 
water), gentamicin eyedrops (Garamycin5) and diclofenac 
eye drops (Voltaren Ophtha6); all four times daily. In 
addition, the horse was treated with systemic procaine 
penicillin (Penovet vet7; 20 000  IU i.m.) twice daily and 
gentamicin (Genta-Kél8; 6.6  mg/kg i.v.) once daily; both 
1 Dechra Veterinary Products A/S, Uldum, Denmark.
2 Pfizer Inc, New York, USA.
3 Nycomed Pharma A/S, Asker, Norway.
4 Bristol-Myers Squibb Company, New York, USA.
5 Schering-Plough International, Kenilworth, New Jersey, USA.
6 Novartis Healthcare A/S, København, Denmark.
7 Boehringer Ingelheim Danmark A/S, København, Denmark.
8 Kela N.V., Hoogstraten, Belgium.
for 5 days. A continuous gradual improvement was seen 
until the horse was deemed sound by the owner around 
day 55, and all treatment was discontinued.
At day 69, however, symptoms similar to those 
described at day 1 recurred, and again, L. monocytogenes 
and Micrococcus sp. were cultured. Treatment with topi-
cal ciprofloxacin eyedrops (Cilox9) and diclofenac eye 
drops [Voltaren Ophtha (see footnote 6)]; both four times 
daily, was initiated. At day 114 the horse was hospitalized 
at the NSVS equine clinic.
Ophthalmic examination at the NSVS confirmed 
abnormal findings restricted to the cornea and the con-
junctiva. The fluorescein dye test was still negative. Bacte-
rial swabs were collected both prior to and after epithelial 
scrapings for cytology, which resulted in considerable 
epithelial detachment. L. monocytogenes was cultured 
from both bacterial swabs, but the highest numbers were 
found prior to scraping. No fungi were cultured. Cytol-
ogy revealed a high number of rods associated with the 
squamous epithelial cells that were seen both as aggre-
gates and isolated. No neutrophils or fungi were seen.
A sub-palpebral lavage system attached to a continuous 
infusion pump system10 was inserted through the upper 
eyelid. Benzylpenicillin sodium (Penicillin 600  mg11 in 
5 ml sterile water) and gentamicin [Garamycin (see foot-
note 5)] eye drops were mixed daily and used in the infu-
sion pump. In addition, the horse was given systemic 
procaine penicillin [Penovet vet (see footnote 7); 
20,000  IU i.m.] twice daily for 10  days, and systemic 
vedaprofen [Quadrisol vet (see footnote 2); 1 mg/kg after 
an initial dose of 2 mg/kg] once daily for 15 days.
At day 118, the footplate of the lavage system was 
noted to have caused a superficial ulceration in the dor-
sal cornea. The infusion set was therefore removed, and a 
new set was inserted in the nasal part of the lower eye lid, 
thereby protected by the membrana nictitans. The cor-
neal lesion created by the lavage system healed unevent-
fully within a week, indicating a normal corneal healing 
ability.
At day 128, at which no bacteria were identified in a 
follow-up cytological evaluation, the apparently irri-
tating topical benzylpenicillin sodium treatment was 
discontinued. Topical treatment with gentamicin [Gar-
amycin (see footnote 5)] eye drops via the lavage system 
was maintained. The following days the inflammation 
was gradually reduced. At day 140, severe kerato-con-
junctivitis recurred. Slides for cytological examination 
were prepared, of which one contained a high number 
of bacteria morphologically identical to L.monocytogenes 
9 Alcon Laboratories, Inc., Fort Worth Texas, USA.
10 Mila International, http://milainternational.com/.
11 Actavis Group, Hafnarfjordur, Iceland.
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associated with squamous epithelial cells. Interestingly, 
such bacteria were not seen on three further slides. The 
combined treatment with benzylpenicillin sodium [Peni-
cillin 600 mg (see footnote 11) in 5 ml sterile water] and 
gentamicin [Garamycin (see footnote 5)] eye drops via 
continuous flow was restarted, but financial constraints 
made further treatment at the clinic impossible. Due to 
the nervous disposition of the horse, enucleation was not 
considered to be an option.
The horse was therefore released from the clinic against 
medical advice on day 150, and treated by the owner with 
oxytetracyclin/polymyxin B [Terramycin-Polymyxin 
B (see footnote 2)] eye ointment three times daily in an 
attempt to control the infection. Four weeks later, the 
horse was involved in a car accident and had to be eutha-
nized due to its injuries.
Case 2
A 7-year-old grey Connemara gelding with a history of 
recurrent unilateral kerato-conjunctivitis the last 
6  months was referred to the NSVS. The pony was fed 
hay and a commercial concentrate mix, but was also fed 
plastic wrapped haylage from the ground of the paddocks 
at daytime. Although treatment with chloramphenicol 
eye ointment [Chloramphenicol (see footnote 3)] and 
diclofenac eye drops [Voltaren Ophtha (see footnote 6)] 
appeared to be effective, clinical signs recurred repeat-
edly after treatment withdrawal. The pony exhibited a 
marked blepharospasm of the left eye, a moderate perior-
bital edema with moderately hyperemic and chemotic 
palpebral conjunctivae, combined with a mild serous dis-
charge. Slightly nasal to the centre of the cornea, there 
was a faint, diffusely outlined greyish-white epithelial and 
sub-epithelial opacity of approximately 2–3  mm diame-
ter. There were no signs of uveitis. A bacterial swab was 
collected prior to the fluorescein dye test, which revealed 
a strong dye uptake in the centre of the lesion. There were 
no signs of neovascularisation. A corneal scraping for 
cytological evaluation resulted in epithelial detachment 
in an area of approximately 4 × 4 mm. The preliminary 
diagnosis was kerato-conjunctivitis of possible viral aeti-
ology. Treatment with idoxuridine eye ointment 
(Iducher12) four times daily, fucidic acid eye drops [Fuc-
ithalmic (see footnote 1)] twice daily and diclofenac eye 
drops [Voltaren Ophtha (see footnote 6)] three times 
daily was initiated. The cytological findings indicated 
possible listeria keratitis. This was confirmed by culturing 
of L. monocytogenes. Based on the results of the sensitiv-
ity testing, topical antibiotics were changed to oxytetra-
cyclin/polymyxin B [Terramycin-Polymyxin B (see 
12 Farmigea S.p.A., Pisa, Italy.
footnote 2] three times daily, and antiviral and anti-
inflammatory treatment was continued.
On day 12, the opacities were hardly visible, and there 
was no discharge or signs of conjunctivitis. Treatment 
with oxytetracyclin/polymyxin B [Terramycin-Poly-
myxin B (see footnote 2)] and idoxuridine eye ointment 
[Iducher (see footnote 12)] was continued for another 
7 days, while diclofenac was discontinued.
On day 29, the pony was re-examined. The symptoms 
had gradually returned, and the owner had restarted 
treatment with oxytetracyclin/polymyxin B [Terramycin-
Polymyxin B (see footnote 2)]. There was a diffuse stro-
mal edema in the ventronasal cornea, surrounding 
several white “spots” of approximately 1  mm diameter. 
The left pupil was slightly miotic consistent with mild 
anterior uveitis, but successfully dilated after 1 drop of 
1  % atropine eye drops (Atropin Minims13). Treatment 
with oxytetracyclin/polymyxin B [Terramycin-Polymyxin 
B (see footnote 2)], idoxuridine eye ointment [Iducher 
(see footmote 12)] and diclofenac eyedrops [Voltaren 
Ophtha (see footnote 6)] as described above was 
restarted. Again, L. monocytogenes was cultured from a 
bacterial swab from the corneal lesions. Around day 45, 
the horse was judged sound by the owner, and all medica-
tion was discontinued.
On day 76, the same symptoms recurred. Treatment 
with ciprofloxacin eye drops [Cilox (see footnote 9)] QID 
was started, and maintained for 4 weeks. In a telephone 
interview 6 years later, the owner reported that the pony 
had shown no symptoms of ocular disease since this 
treatment. They had, however, also stopped using haylage 
in the paddocks.
Case 3
A 10-year-old Icelandic horse, which was kept in a 
group and fed plastic wrapped silage, was referred to the 
NSVS for evaluation of kerato-conjunctivitis in the right 
eye of 1  month duration. Despite initial improvement 
after treatment with fucidic acid eye drops [Fucithalmic 
(see footnote 1)] twice daily for 10  days, the symptoms 
recurred when treatment was stopped. The same treat-
ment was re-initiated, this time without noticeable effect.
The horse was presented with a mild blepharospasm of 
the right eye, a moderate periorbital edema with mod-
erately hyperaemic and chemotic palpebral conjuncti-
vae. Slightly nasal to the centre of the cornea, there was 
a very faint grayish epithelial opacity, only visible with a 
focal light source. No further pathology was seen. A bac-
terial swab was collected as previously described. The 
13 Bausch & Lomb U.K. Ltd., Surrey, England.
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fluorescein dye test was negative. Treatment with chlo-
ramphenicol eye ointment [Chloramphenicol (see foot-
note 3)] three to four times daily and diclofenac eye drops 
[Voltaren Ophtha (see footnote 6)] two to three times 
daily was initiated awaiting sampling results.
At day 6, L. monocytogenes was cultured from a bacte-
rial swab. The topical antibiotic treatment was changed to 
ciprofloxacin eyedrops [Cilox (see footnote 9)] four times 
daily for 4 weeks. At day 30, the owner reported that the 
symptoms were reduced, but that a mild epiphora was 
still present. The treatment was therefore prolonged for 
another 14 days.
A few days after discontinuation of treatment, the 
symptoms recurred. At re-examination on day 48, the 
clinical findings were identical to those described at day 
1. A new bacterial swab revealed continuous growth of L. 
monocytogenes without changes to the sensitivity pattern. 
Due to the poor clinical effect of ciprofloxacin, treatment 
was changed back to chloramphenicol [Chlorampheni-
col (see footnote 3)] eyedrops 5 times daily (ointment 
at night) for 6 weeks. Around day 90, the owner discon-
tinued the treatment without further veterinary con-
sultation. The following days symptoms as originally 
described recurred. On day 104 the horse was hospital-
ized at the NSVS.
The diffusely outlined epithelial opacity was still faint, 
but now covering more than 50 % of the corneal surface. 
A few superficial stromal, very thin blood vessels were 
now seen progressing approximately 7 mm from the dor-
sal limbus. Mild uptake of fluorescein dye was found in a 
5 mm diameter area located 5–10 mm from the ventro-
nasal limbus.
The horse was treated with a continuous flow of chlo-
ramphenicol eyedrops [Chloramphenicol (see footnote 
3)] via a superior subpalpebral lavage system attached 
to a continuous infusion pump system (see footnote 10) 
for 14 days and systemic procaine penicillin [Penovet vet 
(see footnote 7); 20,000  IU i.m.] twice daily for 10 days. 
At day 118 there were no signs of conjunctivitis, but still 
a faint epithelial opacity. The horse was sent home on 
another 14 days of chloramphenicol eye ointment [Chlo-
ramphenicol (see footnote 3)] four times daily.
According to a telephone interview with the owner at 
day 191 the horse had not showed signs of ocular disease 
after termination of treatment at day 132. Around day 
280, the horse was presented to a field practitioner with 
bilateral conjunctivitis. Bacterial swabs were collected 
from both eyes and submitted to the NSVS for culturing. 
A mixed flora was cultured, dominated by Staphylococcus 
aureus in the right eye and Pasturella sp in the left eye; 
both sensitive to chloramphenicol. L. monocytogenes was 
not found at this stage.
Case 4
An 8-year-old Icelandic pony with a six month history of 
unilateral recurrent kerato-conjunctivitis, affecting the 
left eye was presented to the horse clinic at Bjerke Equine 
Hospital, Oslo. The owner had first noticed a problem 
approximately 5  months earlier whilst the horse was at 
pasture and described symptoms of recurrent blepha-
rospasm with ocular discharge. The eye was treated topi-
cally on several occasions with no lasting improvement, 
however the examination findings and medications used 
are not known. Three months after the symptoms were 
first noticed, a superficial corneal ulcer associated with a 
corneal foreign body was observed by the attending vet-
erinary surgeon. During the past 2 months, the horse had 
been fed plastic wrapped haylage from the ground. The 
foreign body was removed and the loose corneal epithe-
lium surrounding the ulcer was debrided. The eye was 
medicated with topical chloramphenicol eye ointment 
[Chloramphenicol (see footnote 3)] three times daily for 
1 week.
Two months after removal of the foreign body the 
horse was presented to Bjerke Equine Hospital due to 
persistent problems with the eye. On examination the eye 
showed moderate blepharospasm with slight epiphora. 
No sign of anterior uveitis was evident. The cornea had a 
dull appearance and there was a small area of epithelium, 
approximately 1  cm in diameter, in the central cornea 
which had an uneven, stippled appearance. Fluorescein 
and Rose Bengal staining was negative. No further abnor-
malities were found.
The cornea was treated topically with neomycin sul-
phate, polymyxin B sulphate and dexamethasone [Max-
itrol (see footnote 9)] three times daily. The owner 
noticed an immediate improvement and on re-examina-
tion 1 week later the horse exhibited no blepharospasm 
or ocular discharge. The corneal surface was shiny and 
smooth. The only abnormality noticed was several very 
small, <1  mm, white sub-epithelial opacities in the cen-
tral cornea. Medication was continued for one week.
Two to three days after treatment was discontinued, 
the owner noticed that the horse was showing signs of 
ocular discomfort once more. Treatment with topical 
0.1 % dexamethasone disodium phosphate (Spersadex14) 
three times daily was instigated. The eye showed no 
improvement and was presented for re-examination 
2 weeks later.
At re-examination the horse showed obvious blepha-
rospasm and significant epiphora. The ventral palpebral 
conjunctiva was chemotic. A superficial corneal ulcer 
was present in the central corneal area, approximately 
8 × 5 mm, which was associated with a very mild, diffuse 
14 OmniVison AB, Danderyd, Sweden.
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edema. The pupil was moderately miotic, indicating mild 
anterior uveitis. No corneal neovascularization was evi-
dent. Fluorescein testing resulted in a faint staining of the 
ulcer margins.
The epithelial surface was carefully scraped and slides 
prepared for cytology, thereby removing loosely adherent 
epithelium in an area of approximately 15 ×  15  mm. A 
swab for bacterial and fungal culture was collected from 
the affected area of the cornea.
Whilst awaiting the results for the samples taken, the 
horse was hospitalized and the eye treated topically with 
oxytetracyclin/polymyxin B [Terramycin-Polymyxin B 
(see footnote 2)] three times daily. A 1  % atropine eye-
drop [Atropin Minims (see footnote 13)] was applied on 
one occasion which resulted in a profound mydriasis. In 
addition the horse was treated with systemic flunixin 
meglumine (Finadyne Vet15; 1,1 mg/kg iv) once daily for a 
period of 5 days. After 5 days the horse showed no ocular 
discomfort or inflammation; the ulcer had healed and 
fluorescein staining was negative. At this point the horse 
was discharged and the owner continued with the antibi-
otic treatment for a further 7 days. Cytology revealed the 
presence of many rod-shaped bacteria in short chains 
indicative of L. monocytogenes. The bacteria were associ-
ated with squamous epithelial cells (Fig. 1). From the cor-
neal swab it was cultured a sparse, mixed bacterial 
growth dominated by L. monocytogenes.
The horse was re-examined 5  days after cessation of 
antibiotic treatment, 12  days after discharge from the 
15 Intervet International B.V, Boxmeer, The Netherlands.
hospital. On examination the horse showed no blepha-
rospasm or ocular discharge. The conjunctivae were not 
inflamed and the cornea was smooth with a healthy, shiny 
corneal surface. No corneal ulcer, edema or neovasculari-
sation was evident. Fluorescein and Rose Bengal staining 
was negative. Three small, <1  mm, white, sub-epithelial 
opacities in the area of previous ulceration were still visi-
ble with magnification. No bacterial growth was cultured 
from a corneal swab. Four months after discharge, the 
owner reported no sign of recurrence.
A brief overview of key clinical observations, culturing 
results and treatments in all four cases is given in Table 1.
Bacteriological examination and findings
In all cases, samples for microbiology were collected dur-
ing the initial examination and for follow-up and evalua-
tion of treatment response. Sterile cotton swabs in Amies 
transport medium without charcoal (Copan M40 Tran-
system16) were used for transporting swab specimens to 
the bacteriological and mycological diagnostic laboratory 
at the NSVS, where culturing was started within a few 
hours after sampling.
Media and cultivation
The samples were in all cases incubated on parallel agar 
plates (blood agar base no 1)17 with 5  % cattle blood of 
which one was incubated at 37 °C in 5 % CO2 atmosphere 
for 24 h while the other was incubated anaerobically for 
48  h. The samples were also inoculated in serum broth 
16 Copan Italia S.p.A., Brescia, Italy.
17 Difco Laboratories Inc., Detroit, Michigan, USA.
Fig. 1 a. Squamous epithelial cell with typical rod‑shaped bacteria on the surface. Note the absence of inflammatory cells. ×600 Modified Wright 
stain. b The rod‑shaped bacteria are suggestive of L. monocytogenes. ×1000 Modified Wright stain
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(see footnote 17) and incubated at 37  °C in 5  % CO2 
atmosphere for 24  h for enrichment of growth for sec-
ondary plating on blood agar in case of no visual growth 
on primary blood agar after 24 h.
In addition, the samples were routinely incubated on 
bromothymol blue agar used for detection of bacteria in 
the Enterobacteriaceae family and other Gram-negative 
rods.
Materials from samples were also directly Gram stained 
to detect any bacteria in the sample before cultivation.
Culture examination and biochemical tests
Growth on the plates was examined followed by record-
ing of morphological and other features of the colo-
nies such as occurrence of any haemolytic zones. Gram 
stained colony material was examined and cell morphol-
ogy recorded. Potential Listeria-like colonies were sec-
ondarily streaked on blood agar plates at right angles 
close to simultaneously streaked cultures of Staphylococ-
cus pseudintermedius and Rhodococcus equi to detect any 
CAMP phenomenon.
Biochemical tests of Listeria-like colonies included the 
catalase test, fermentation of glucose, degradation of aes-
culin, hippurat and H2S. The methyl red, Voges Proskauer 
and motility tests (in semi-liquid agar grown at 22 and 
37 °C) were also performed.
Bacteriological findings from all eye swab samples 
collected during the course of the disease in all cases 
are summarized in Table 1. Colonies suspected to be L. 
monocytogenes were 1.0  mm in diameter, convex and 
grey to white in colour with a clear zone of β-haemolysis 
extending barely (about 0.5 mm) outside the colony edge. 
There was no growth on bromothymol blue agar from 
any of the corneal swabs. There was no evidence of any 
antibacterial agent in the material from initial corneal 
swabs as seen from the control growth of S. pseudinter-
medius on the blood agar incubated in CO2 atmosphere. 
The same type of colony was detected on blood agar after 
cultivation from the LB enrichment broth after one, two 
and 3 days. In all four cases culturing revealed a low to 
moderate number of colonies in pure culture with similar 
cultural characteristics to L. monocytogenes (Table 1).
Phenotypical and biochemical features of β‑hemolytic 
colonies
The β-hemolytic colonies from the corneal swabs con-
tained bacteria that were Gram positive, short coccoid 
and regular sized rods. The isolates were catalase posi-
tive, fermented glucose, did not metabolise aesculin or 
hippurate, produced H2S, and were negative on methyl 
red and Voges Proskauer tests. They were non-motile on 
semi-solid agar at 37 °C, but motile at 22 °C. They showed 
weak CAMP reaction with β-toxic S. pseudintermedius 
but were CAMP negative with R. equi. The biochemical 
profile and phenotypic features suggest that the colonies 
were L. monocytogenes.
Serotyping and antimicrobial susceptibility testing
Incubation of the test samples and cultures of L. monocy-
togenes reference strains CCUG 15527 (serotype 1) and 
CCUG 7995 (serotype 4) for 24 h at 37 °C demonstrated 
that the isolated L. monocytogenes of all cases belonged to 
the O serotype 1 judged by the phenotypical similarity of 
the colonies and their haemolytic zones.
Agglutination tests performed on glass slides with anti-
sera against Listeria O type 1 (see footnote 17) and Lis-
teria O type 4 (see footnote 17) also showed the same 
result. Antimicrobial susceptibility tests were carried out 
using the tablet diffusion method with twelve different 
antibacterial drugs including penicillin, ampicillin, 
cefalexin, amoxycillin, amoxycillin with clavulanic acid, 
sulphadiazine/trimethoprim, tetracycline, gentamicin, 
lincomycin, chloramphenicol, fucidic acid, enrofloxacin, 
and colicin. Agar diffusion on Müller-Hinton (MH) agar 
(see footnote 17) was used with tablets containing antibi-
otics (Neo-Sensitabs)18 for the susceptibility tests. The 
tests showed that isolates of L. monocytogenes from all 
four cases were found to be either moderately susceptible 
or in some cases resistant towards fucidic acid. The iso-
lates of L. monocytogenes from case 3 and 4 (both from 
the initial and follow-up isolations) were found to be 
intermediate susceptible towards enrofloxacin. The iso-
lates were found to be susceptible to all other antimicro-
bial drugs tested.
General discussion
The four cases of kerato-conjunctivitis in horses associ-
ated with L. monocytogenes reported in this study repre-
sent the first reported cases in Scandinavia.
L. monocytogenes is a facultative intracellular pathogen 
widely distributed in the environment where most ani-
mals are exposed to the organism during their lifetime. 
The bacterium causes disease either when the host’s 
immune system is compromised or when the bacterium 
occurs in numbers high enough to overwhelm the host’s 
defence mechanisms [2, 9, 11]. Although the common 
route of infection is oral, the bacterium may also enter 
the body through the nasal mucosa or open wounds. 
The conjunctiva has also been mentioned as a possible 
entrance [24, 34]. In contrast to the high frequency of 
ocular signs of listeriosis described in cattle [2], ocular 
listerial infections seem to be rare in horses with only two 
cases reported so far [25, 26].
18 Rosco, Taastrup, Denmark.
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All cases reported here had symptoms of corneal dis-
ease for an extended time period prior to referral. Hence, 
it is not possible to determine the pathogenesis in these 
cases with certainty. L. monocytogenes serotype O type 1, 
a common strain found in the environment, in silage and 
in systemically infected animals [22], was cultured from 
all cases reported here. This is in agreement with the 
theory of silage as the most likely source of infection, and 
with the findings of Evans et al. [26] that ocular listerial 
infections seem to be caused by common strains of the 
bacterium that are also found in systemic infection.
The intact and healthy cornea is highly resistant to 
bacterial infection, due to a continuous flow of a tear 
film with antimicrobial properties, as well as the physi-
cal barrier of a healthy epithelium [27]. It has, however, 
been shown that L. monocytogenes may penetrate into 
undamaged corneal epithelial cells of guinea pigs [28]. 
Further, conjunctivitis and/or kerato-conjunctivitis has 
been induced experimentally in guinea pigs and rabbits 
simply by direct inoculation of L. monocytogenes, while 
similar direct inoculation of a variety of other bacteria 
did not cause infection [29]. In fact, this characteristic 
ability to cause conjunctivitis and keratitis was in 1939 
even proposed as a method to identify an infectious cul-
ture as L. monocytogenes [30]. It has also been shown that 
the infectivity of listerial cultures after direct inoculation 
in rabbits is dose dependent [9]. Whether direct inocula-
tion would cause kerato-conjunctivitis in a horse remains 
speculative, not least given the more than 3 times thicker 
corneal epithelium in horses [31, 32] compared to rabbits 
[33].
There is a well-known general association between 
silage feeding and listeriosis [5, 34–37]. In horses, sys-
temic L. monocytogenes infections have been associated 
with silage feeding [22, 26], feeding on poor quality hay 
[17] or grazing on spray and flood-irrigated grass clover 
pasture [14]. Plastic wrapped forage (silage or haylage) is 
commonly used to feed horses in Norway, especially dur-
ing the winter season, and appears to be the most likely 
source of L. monocytogenes in the cases described here. 
Grass silage produced in cool, wet climates tends to have 
lower sugar levels and higher moisture contents than 
silage produced in warmer climates. This may result in 
a poorer and slower fermentation, which provides bet-
ter conditions for the proliferation of L. monocytogenes in 
the silage [38]. Poor quality hay or soil-contaminated for-
age represent other possible sources of infection in these 
cases.
In several studies, feeding of animals with silage placed 
at or above head height in such a way that silage mate-
rial could fall into the eyes of the animals has been 
incriminated as a possible predisposing factor of listerial 
eye infection [35, 37, 39]. Such feeding routines are not 
common in horses. Still, frozen forage or forage made 
into a hard bale as in silage or haylage may be difficult to 
pretend, and horses may pull forage out of the bale and 
throw it up in the air, increasing the likelihood of ocular 
exposure to contaminated material. Hence, it appears 
possible that feeding routines, although not further 
investigated, may have played a role in these cases.
Corticosteroid treatment is known to increase the 
infectivity of L. monocytogenes in laboratory animals [1]. 
The case of equine listerial keratitis reported by Sanchez 
et al. [25] had been treated with topical steroids prior to 
referral. Only one of the horses included in this report 
(case 4) had been treated with topical steroids prior to 
the identification of L. monocytogenes, and no other signs 
of immunosuppression were identified in any of these 
cases.
L. monocytogenes is often detected in low numbers by 
cultivation, sometimes together with other bacteria. This 
observation is important for the bacteriologist when 
cultivating samples from cases of keratitis, and may be 
related to the intracellular growth of L. monocytogenes. 
The low number of Listeria bacteria seen on culturing 
may have contributed to the low number of reported 
cases in the literature. Also, as noted by other authors 
there may be lacking awareness among clinicians as well 
as bacteriologists regarding the potential role of L. mono-
cytogenes in ocular infections [9, 11, 26]. A thorough 
cytologic evaluation of corneal scrapings was found to be 
of great help in these cases, but comprehensive sampling 
is crucial as indicated by positive findings in only one out 
of several slides at the last recurrence in case 1.
Listerial infections are commonly treated with penicil-
lins or tetracylines, which may be effective in early stages 
of systemic disease. However, if severe symptoms have 
developed prior to initiation of intensive antibiotic treat-
ment, the outcome is commonly fatal [2].
Combined use of gentamycin and penicillin was found 
to be more effective than either of the antibiotics used 
alone in treatment of experimental listerial keratitis in 
rabbits [9]. The same combination of antibiotics was used 
systemically as well as topically for successful treatment 
of a severe case of human listerial keratitis [9].
Based on these findings, penicillins (ampicillin or 
penicillin G) and gentamicin were used systemically and 
topically in case 1. Some comments need to be made 
regarding this combined treatment: The low lipophi-
licity of Penicillin G likely restricts its ability to pen-
etrate the barrier of the lipophilic corneal epithelium. 
Although topical penicillin treatment has been recom-
mended for use in humans with ocular surface disease 
[40], the poor penetration of the epithelium may well 
limit the efficacy of the drug against intracellularly 
located strains of Listeria. Notable in this context is the 
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fact that the horses in this study on many occasions had 
intact epithelium covering the corneal lesions, as dem-
onstrated by negative Fluorescein dye tests. Further, 
aminoglycosids may be inactivated in plasma in approx-
imately 8–48  h in the presence of ß-lactams [41]. In 
order to minimize inactivation, a fresh mixture for con-
tinuous flow treatment was prepared daily in case 1. The 
extent of potential aminoglycoside inactivation was not 
investigated. Despite these factors, this combined treat-
ment appeared to be effective, but was probably stopped 
too early.
Various other recommendations have been published 
with regards to treatment of ocular listerial infections. 
Both the previously reported cases of listerial kerato-
conjunctivitis in horses were treated successfully with 
kinolones (alone or in combination) [25, 26]. Based on 
these reports, the kinolone Ciprofloxacin was used in 
cases 1–3, but this treatment was only successful in case 
2. These treatments were carried out by the horse own-
ers, and it is possible that the lack of success may have 
been related to owners’ compliance. On the other hand, 
failure of listerial keratitis to respond to treatment with 
the kinolone Ofloxacin despite in vitro susceptibility has 
been reported in a human patient [10]. Interestingly, the 
isolates from cases 3 and 4 were found to be intermedi-
ate susceptible towards enrofloxacin, which was the only 
kinolone available for susceptibility testing.
The isolates described here were found to be suscepti-
ble to most of the antibiotics tested, but intermediately 
susceptible or in some cases resistant to fucidic acid. 
Fucidic acid is commonly used as a “first choice” antibi-
otic to treat suspected bacterial keratitis or conjunctivitis 
in Norway, and had been used prior to referral at least in 
cases 1 and 3.
Despite extremely prolonged unsuccessful treatment 
with chloramphenicol in case 3, hospitalization and 
intensified treatment with continuous flush using the 
same antibiotic led to final resolution of the symptoms, 
although this final treatment was supplemented by sys-
temic penicillin for 10  days. Although the possibility of 
re-infections cannot be completely ruled out, we believe 
recurrences of symptoms in these horses after termi-
nation of treatment were related to lack of successful 
elimination of the infective agent, not least due to the 
consistent unilaterality of the clinical signs. In summary, 
we believe that several antibiotics may be used success-
fully for treatment, but that extra attention must be paid 
to intensity and duration of treatment once L. monocy-
togenes has been identified in cases of equine kerato-
conjunctivitis. Cases should also be monitored closely 
after termination of antibiotic treatment. Difficulties in 
treatment similar to those described here have also been 
reported in human ophthalmology [9–11, 42].
Conclusions
L. monocytogenes should be considered a potential patho-
gen in cases of indolent bacterial kerato-conjunctivitis in 
horses, especially in animals fed with silage or haylage.
Special attention may be required from clinicians as 
well as bacteriologists and clinical pathologists in order 
to identify the bacteria. The generally poor response 
to treatment and frequent recurrences in the cases 
described here indicate that clinicians should pay extra 
attention to the choice of antimicrobial drugs, and to 
the intensity and duration of the treatment regimen if L. 
monocytogenes is identified from equine keratitic lesions. 
Further research is needed to determine whether L. 
monocytogenes may act as a primary pathogen, or rather 
as a secondary invader in cases of pre-existing corneal 
lesions.
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